These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 19708297)

  • 1. [Relation of C-reactive protein and coronary heart disease. Current knowledges].
    Biasillo G; De Maria GL; Leo M; Stefanelli A; Biasucci LM
    Recenti Prog Med; 2009 Jun; 100(6):279-85. PubMed ID: 19708297
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical implications of C-reactive protein as a predictor of vascular risk.
    Katrinchak C; Fritz K
    J Am Acad Nurse Pract; 2007 Jul; 19(7):335-40. PubMed ID: 17680898
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Value of CRP in coronary risk determination.
    Mehta JL; Sukhija R; Romeo F; Sepulveda JL
    Indian Heart J; 2007; 59(2):173-7. PubMed ID: 19122252
    [TBL] [Abstract][Full Text] [Related]  

  • 4. C-reactive protein is a bystander of cardiovascular disease.
    Anand SS; Yusuf S
    Eur Heart J; 2010 Sep; 31(17):2092-6. PubMed ID: 20675658
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Should physicians measure high-sensitivity C-reactive protein levels to assess coronary heart disease risk?
    Alpert JS
    Am J Med; 2009 May; 122(5):405-6. PubMed ID: 19375543
    [No Abstract]   [Full Text] [Related]  

  • 6. C-reactive protein but not soluble CD40 ligand and homocysteine is associated to common atherosclerotic risk factors in a cohort of coronary artery disease patients.
    Vivona N; Bivona G; Noto D; Sasso BL; Cefalù AB; Chiarello G; Falletta A; Ciaccio M; Averna MR
    Clin Biochem; 2009 Nov; 42(16-17):1713-8. PubMed ID: 19732763
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of C-reactive protein (CRP) and statin treatment in reducing cardiovascular risk.
    Chin J
    S D Med; 2009 Mar; 62(3):104-6. PubMed ID: 19480274
    [No Abstract]   [Full Text] [Related]  

  • 8. C- Reactive protein, cardiac troponin T and low albumin are predictors of mortality in hemodialysis patients.
    Bagheri N; Taziki O; Falaknazi K
    Saudi J Kidney Dis Transpl; 2009 Sep; 20(5):789-93. PubMed ID: 19736474
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of cell function by isoforms of C-reactive protein: a comparative analysis.
    Boncler M; Watała C
    Acta Biochim Pol; 2009; 56(1):17-31. PubMed ID: 19219228
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Perspective: risk apportionment and disease intervention strategies.
    Barraj LM; Tran NL; Goodman M; Ginevan ME
    Risk Anal; 2008 Apr; 28(2):477-86. PubMed ID: 18419663
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reducing cardiovascular risk: trends in risk, risk assessment, and cholesterol management.
    Davidson MH
    Postgrad Med; 2004 Sep; 116(3 Suppl):7-12. PubMed ID: 19667670
    [TBL] [Abstract][Full Text] [Related]  

  • 12. C-reactive protein (CRP): more than just an innocent bystander?
    Paraskevas KI; Mikhailidis DP
    Curr Med Res Opin; 2008 Jan; 24(1):75-8. PubMed ID: 18021498
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical inquiries: how much does smoking cessation cut CHD risk?
    Frothingham SM; Smith PO; Payne TJ; Meadows SE
    J Fam Pract; 2008 Oct; 57(10):675-6. PubMed ID: 18842195
    [No Abstract]   [Full Text] [Related]  

  • 14. C-reactive protein--does it promote vascular disease?
    Stenvinkel P
    Nephrol Dial Transplant; 2006 Oct; 21(10):2718-20. PubMed ID: 16861733
    [No Abstract]   [Full Text] [Related]  

  • 15. The long pentraxin 3 (PTX3): a novel prognostic inflammatory marker for mortality in acute chest pain.
    Brügger-Andersen T; Pönitz V; Kontny F; Staines H; Grundt H; Sagara M; Nilsen DW
    Thromb Haemost; 2009 Sep; 102(3):555-63. PubMed ID: 19718477
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of quality of dietary fat on serum cholesterol and coronary heart disease: focus on plant sterols and other non-glyceride components.
    Ghafoorunissa
    Natl Med J India; 2009; 22(3):126-32. PubMed ID: 19764688
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Linking observational and genetic approaches to determine the role of C-reactive protein in heart disease risk.
    Hingorani AD; Shah T; Casas JP
    Eur Heart J; 2006 Jun; 27(11):1261-3. PubMed ID: 16684780
    [No Abstract]   [Full Text] [Related]  

  • 18. Relation of obesity to heart failure hospitalization and cardiovascular events in persons with stable coronary heart disease (from the Heart and Soul Study).
    Spies C; Farzaneh-Far R; Na B; Kanaya A; Schiller NB; Whooley MA
    Am J Cardiol; 2009 Oct; 104(7):883-9. PubMed ID: 19766751
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiovascular disease: is C-reactive protein the bad guy?
    Ahmed MH
    Diabetes Res Clin Pract; 2007 Jun; 76(3):472-3. PubMed ID: 17055102
    [No Abstract]   [Full Text] [Related]  

  • 20. C-reactive protein and coronary artery disease-what is the link?
    Koenig W; Wanner C
    Nephrol Dial Transplant; 1999 Dec; 14(12):2798-800. PubMed ID: 10570070
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.